[VIVO] YoY Quarter Result on 30-Sep-2020 [#Q4]

Stock
[VIVO] Meridian Bioscience, Inc.
Announcement Date
23-Nov-2020
Financial Year
2020
Quarter
30-Sep-2020 [#Q4]
Profit Trend
QoQ- -76.40%
YoY- 58.25%
Quarter Report
VIVO's Result
VIVO's Financial Summary
View:
Show?
Quarter Result
30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 CAGR
Revenue 65,675 76,204 64,153 50,846 53,100 49,697 46,998 5.73%
PBT 4,633 7,856 7,747 5,356 6,878 8,634 8,752 -10.05%
Tax -1,072 1,199 1,254 1,253 1,444 2,908 3,261 -
NP 5,705 6,657 6,493 4,103 5,434 5,726 5,491 0.63%
Tax Rate 23.14% -15.26% -16.19% -23.39% -20.99% -33.68% -37.26% -
Total Cost 59,970 69,547 57,660 46,743 47,666 43,971 41,507 6.32%
Ratio Analysis
30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 CAGR
NP Margin 8.69 8.74 10.12 8.07 10.23 11.52 11.68 -4.80%
Per Share
30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 CAGR
EPS 0.13 0.15 0.15 0.10 0.13 0.14 0.13 0.00%
EPS Diluted 0.13 0.15 0.15 0.10 0.13 0.13 0.13 0.00%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.